In:
International Journal of Cancer, Wiley, Vol. 148, No. 6 ( 2021-03-15), p. 1394-1407
Abstract:
Guidelines for high‐risk human papillomavirus (hrHPV) testing in cervical cancer screening were introduced in Colombia in 2014 but have yet to be adopted in clinical practice. Moreover, follow‐up for screen‐positive women, including those with atypical squamous cells of undetermined significance (ASC‐US) cytology is limited. Here, hrHPV testing for follow‐up of women with ASC‐US cytology was compared with two approaches currently available in Colombia, immediate colposcopy and repeat cytology at two‐year routine follow‐up. Compared to immediate colposcopy, hrHPV testing reduced the burden of high‐grade cervical abnormalities by 65 percent and colposcopy referral by 41 percent.
Type of Medium:
Online Resource
ISSN:
0020-7136
,
1097-0215
Language:
English
Publisher:
Wiley
Publication Date:
2021
detail.hit.zdb_id:
218257-9
detail.hit.zdb_id:
1474822-8
Permalink